Unspecified Topical Flea Product

24 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

420.0%

Death Rate

Active Ingredients

Unspecified Topical Flea Product

Administration Routes

TopicalUnknown

Species Affected

Cat 13

Dog 11

Most Affected Breeds

Domestic Shorthair 8

Spitz - German Pomeranian 2

Mixed (Cat) 2

Shepherd Dog - German 1

Pit Bull 1

Shih Tzu 1

Himalayan 1

Papillon - Spaniel - Continental Toy (with erect ears or with dropped ears (Phaléne)) 1

Retriever - Golden 1

Dachshund - Miniature 1

Most Reported Reactions

Lack of efficacy (ectoparasite) - flea 17

Hyperactivity 4

Vocalisation 2

Panting 2

Pruritus 1

Lethargy (see also Central nervous system depression in 'Neurological') 1

Lack of efficacy - NOS 1

Mewing 1

Licking 1

Agitation 1

Warm feeling to the touch 1

Twitching 1

Outcome Breakdown

Outcome Unknown

14 (58.3%)

Recovered/Normal

6 (25.0%)

Ongoing

3 (12.5%)

Euthanized

1 (4.2%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.